Keith Regnante

Companies

• Keros Therapeutics, Inc.Chief financial officer Apr 7, 2020 to now¹
• Wave Life SciencesChief financial officer Aug 17, 2016 to Mar 11, 2019²

Holdings

Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.

Shares held

• KTKeros Therapeutics, Inc. KROS39,261 shares³$435.8K at $11.10Feb 18, 2026

As of each latest filing. The line shows shares held over time.

Recent filings

• Feb 18, 2026Sold 4,739 shares at $16.35 of Keros Therapeutics, Inc.³
• Feb 18, 2025Granted 44,000 shares of Keros Therapeutics, Inc.⁴
• Jan 4, 2024Sold 40,000 shares at $45.29 of Keros Therapeutics, Inc.⁵
• Jan 4, 2024Exercised options 40,000 shares at $16.00 of Keros Therapeutics, Inc.⁵
• Nov 4, 2023Sold 40,000 shares at $45.29 of Keros Therapeutics, Inc.⁶
• Nov 4, 2023Exercised options 40,000 shares at $16.00 of Keros Therapeutics, Inc.⁶
• Jun 9, 2023Sold 2,579 shares at $47.25 of Keros Therapeutics, Inc.⁷
• Jun 9, 2023Sold 1,428 shares at $46.46 of Keros Therapeutics, Inc.⁷
• Jun 9, 2023Sold 15,993 shares at $45.03 of Keros Therapeutics, Inc.⁷
• Jun 9, 2023Exercised options 20,000 shares at $16.00 of Keros Therapeutics, Inc.⁷
• Jun 8, 2023Sold 2,699 shares at $48.65 of Keros Therapeutics, Inc.⁷
• Jun 8, 2023Sold 17,301 shares at $47.66 of Keros Therapeutics, Inc.⁷
• Jun 8, 2023Exercised options 20,000 shares at $16.00 of Keros Therapeutics, Inc.⁷